MCID: FBR054
MIFTS: 43

Fibroma

Categories: Cancer diseases
Data Licensing
For inquiries, contact:

Aliases & Classifications for Fibroma

MalaCards integrated aliases for Fibroma:

Name: Fibroma 11 75 28 53 43 14 16

Classifications:



External Ids:

Disease Ontology 11 DOID:0050871
MeSH 43 D005350

Summaries for Fibroma

Disease Ontology: 11 A connective tissue benign neoplasm composed of fibrous or connective tissues that derives from mesenchymal tissue.

MalaCards based summary: Fibroma is related to ossifying fibroma and skin tag. An important gene associated with Fibroma is MALAT1 (Metastasis Associated Lung Adenocarcinoma Transcript 1), and among its related pathways/superpathways are Cytoskeletal Signaling and Striated muscle contraction pathway. The drugs Prednisolone phosphate and Prednisolone acetate have been mentioned in the context of this disorder. Affiliated tissues include bone, ovary and small intestine, and related phenotypes are homeostasis/metabolism and cellular

Wikipedia: 75 Fibromas are benign tumors that are composed of fibrous or connective tissue. They can grow in all... more...

Related Diseases for Fibroma

Diseases related to Fibroma via text searches within MalaCards or GeneCards Suite gene sharing:

(show top 50) (show all 837)
# Related Disease Score Top Affiliating Genes
1 ossifying fibroma 32.4 USP6 SERPINA3 SATB2 NF1 CDC73 CD34
2 skin tag 32.4 SERPINA3 PTCH1 CD34
3 liver fibroma 32.1 VIM CALB2
4 testicular fibroma 32.0 CTNNB1 CD34 CALB2
5 basal cell nevus syndrome 31.7 PTCH1 NF1 CTNNB1
6 cutaneous fibrous histiocytoma 31.4 SERPINA3 S100A1 F13A1 DES CD68 CD34
7 fibromatosis 31.3 VIM DES CTNNB1 ACTC1
8 chondrosarcoma 31.2 VIM SERPINA3 S100A1 DES
9 desmoid tumor 31.0 DES CTNNB1 CD34 ACTC1
10 fibrosarcoma 31.0 VIM MALAT1 DES ACTC1
11 leiomyoma 30.8 VIM S100A1 DES CD34 ACTC1
12 tenosynovial giant cell tumor 30.7 USP6 SERPINA3 CD68
13 lipomatosis, multiple 30.6 SERPINA3 S100A1 NF1 DES CD34
14 ameloblastoma 30.6 SERPINA3 PTCH1 CTNNB1 CALB2
15 osteoblastoma 30.6 USP6 SATB2 CTNNB1
16 fasciitis 30.6 VIM USP6 DES CD34 ACTC1
17 chondroma 30.6 S100A1 NF1 CTNNB1 ACTC1
18 basal cell carcinoma 30.4 PTCH1 KRT7 F13A1 CTNNB1 CD34 ACTC1
19 perineurioma 30.4 VIM DES CD34 ACTC1
20 epulis 30.4 SERPINA3 KRT7 CDC73 CD68 CD34
21 giant cell reparative granuloma 30.3 USP6 SERPINA3 NF1 CD68
22 mesenchymal cell neoplasm 30.3 SERPINA3 NF1 CTNNB1 CD68 CD34
23 neurofibroma 30.2 VIM S100A1 NF1 F13A1 CD34 ACTC1
24 erythema elevatum diutinum 30.2 S100A9 CD34
25 sarcoma 30.2 VIM SERPINA3 S100A1 DES CTNNB1 CALB2
26 mixed cell type cancer 30.2 SERPINA3 KRT7 CTNNB1 CALB2
27 chordoma 30.2 VIM SERPINA3 S100A1 KRT7 DES CTNNB1
28 well-differentiated liposarcoma 30.2 SERPINA3 NF1 CD34
29 myoma 30.2 CD68 CD34 CALB2 ACTC1
30 myofibroma 30.2 USP6 S100A1 CD34
31 cowden syndrome 30.1 TSC1 PTCH1 NF1 CTNNB1
32 neuroma 30.1 SERPINA3 NF1 CD68 CD34
33 inflammatory myofibroblastic tumor 30.1 CTNNB1 CD68 CD34
34 congenital epulis 30.1 SERPINA3 S100A9 CD68
35 pericardial effusion 30.1 MUC16 CD68 CD34
36 chondroblastic osteosarcoma 30.0 SERPINA3 SATB2
37 mesenchymal chondrosarcoma 30.0 VIM KRT7 DES ACTC1
38 fibrous histiocytoma 30.0 VIM SERPINA3 F13A1 DES CD68 CD34
39 cystadenoma 30.0 SERPINA3 MUC16 KRT7 CALB2
40 obstructive jaundice 29.9 SERPINA3 MUC16 KRT7
41 myoblastoma 29.9 CD68 CALB2
42 benign teratoma 29.9 PTCH1 KRT7 CD34 CALB2
43 pseudosarcomatous fibromatosis 29.9 VIM USP6 SERPINA3 DES CTNNB1 CD68
44 dermatofibrosarcoma protuberans 29.8 VIM SERPINA3 S100A1 F13A1 DES CD68
45 signet ring cell adenocarcinoma 29.8 SERPINA3 KRT7 CTNNB1
46 fibrosarcomatous osteosarcoma 29.8 SERPINA3 SATB2
47 inguinal hernia 29.8 NF1 CD34 CALB2
48 adenoid cystic carcinoma 29.8 VIM SERPINA3 KRT7 CTNNB1 ACTC1
49 verruciform xanthoma of skin 29.8 SERPINA3 CD68
50 cutaneous leiomyosarcoma 29.8 CD68 CD34

Graphical network of the top 20 diseases related to Fibroma:



Diseases related to Fibroma

Symptoms & Phenotypes for Fibroma

MGI Mouse Phenotypes related to Fibroma:

45
# Description MGI Source Accession Score Top Affiliating Genes
1 homeostasis/metabolism MP:0005376 10.16 ACTC1 CD34 CDC73 CTNNB1 DES F13A1
2 cellular MP:0005384 10 ACTC1 CD34 CDC73 CTNNB1 DES KRT7
3 muscle MP:0005369 9.97 ACTC1 CDC73 CTNNB1 DES NF1 PTCH1
4 respiratory system MP:0005388 9.61 CDC73 CTNNB1 F13A1 NF1 PTCH1 S100A1
5 hematopoietic system MP:0005397 9.4 ACTC1 CD34 CD68 CDC73 CTNNB1 F13A1

Drugs & Therapeutics for Fibroma

Drugs for Fibroma (from DrugBank, HMDB, Dgidb, PharmGKB, IUPHAR, NovoSeek, BitterDB):

(show top 50) (show all 53)
# Name Status Phase Clinical Trials Cas Number PubChem Id
1
Prednisolone phosphate Approved, Vet_approved Phase 4 302-25-0
2
Prednisolone acetate Approved, Vet_approved Phase 4 52-21-1
3
Prednisolone Approved, Vet_approved Phase 4 50-24-8 4894 5755
4
Methylprednisolone hemisuccinate Approved Phase 4 2921-57-5 1875
5
Methylprednisolone Approved, Vet_approved Phase 4 83-43-2 4159 6741
6
Prednisolone hemisuccinate Experimental Phase 4 2920-86-7 4897
7
Methylprednisolone Acetate Phase 4 584547
8
Sorafenib Approved, Investigational Phase 3 284461-73-0 216239
9 Protein Kinase Inhibitors Phase 3
10
Toremifene Approved, Investigational Phase 2 89778-26-7 3005573
11
Doxorubicin Approved, Investigational Phase 2 23214-92-8 31703
12
Sirolimus Approved, Investigational Phase 1, Phase 2 53123-88-9 5284616 6436030
13
Miconazole Approved, Investigational, Vet_approved Phase 1, Phase 2 22916-47-8 4189
14
Clotrimazole Approved, Vet_approved Phase 1, Phase 2 23593-75-1 2812
15
Denosumab Approved Phase 2 615258-40-7
16
Cathine Approved, Experimental, Illicit, Vet_approved, Withdrawn Phase 2 14838-15-4, 492-39-7 131954576 4786 26934
17
Guaifenesin Approved, Investigational, Vet_approved Phase 2 93-14-1 3516
18
Nivolumab Approved Phase 2 946414-94-4
19
Ipilimumab Approved Phase 2 477202-00-9
20
Imidazole Experimental, Investigational Phase 2 288-32-4 795
21 Vaccines Phase 2
22 Estrogens Phase 2
23 Hormones Phase 2
24 Hormone Antagonists Phase 2
25 Antineoplastic Agents, Hormonal Phase 2
26 Estrogen Receptor Modulators Phase 2
27 Selective Estrogen Receptor Modulators Phase 2
28
Imatinib Mesylate Phase 2 220127-57-1
29 Immunosuppressive Agents Phase 1, Phase 2
30 Immunologic Factors Phase 1, Phase 2
31 Liposomal doxorubicin Phase 2
32 Anti-Bacterial Agents Phase 1, Phase 2
33 Anti-Infective Agents Phase 1, Phase 2
34 Antifungal Agents Phase 1, Phase 2
35 Antibiotics, Antitubercular Phase 1, Phase 2
36 Chlorpheniramine, phenylpropanolamine drug combination Phase 2
37 Immunoglobulins Phase 2
38 Immune Checkpoint Inhibitors Phase 2
39 Antibodies, Monoclonal Phase 2
40 Antibodies Phase 2
41 Antineoplastic Agents, Immunological Phase 2
42
Triamcinolone Approved, Vet_approved Phase 1 124-94-7 31307
43
Triamcinolone hexacetonide Phase 1
44
Triamcinolone diacetate Phase 1
45
Triamcinolone Acetonide Phase 1 6436
46 glucocorticoids Phase 1
47 Anti-Inflammatory Agents Phase 1
48
Estradiol Approved, Investigational, Vet_approved Early Phase 1 50-28-2 5757
49
Polyestradiol phosphate Approved Early Phase 1 28014-46-2
50 Cola

Interventional clinical trials:

(show all 38)
# Name Status NCT ID Phase Drugs
1 Prospective Trial Comparing the Performance Profiles of Two Non-Cross-Linked Porcine Dermal Matrices in Abdominal Wall Reconstruction Recruiting NCT02228889 Phase 4
2 Percutaneous Needle Fasciotomy (PNF) +/- Corticosteroid Injection for Dupuytren's Contracture (DC) Affecting Metacarpophalangeal Joints (MCP) . A Randomized Controlled Trial Not yet recruiting NCT05440240 Phase 4 Corticosteroid injection
3 A Randomized, Double-Blind, Placebo-Controlled, Phase 3 Trial of Nirogacestat Versus Placebo in Adult Patients With Progressing Desmoid Tumors/Aggressive Fibromatosis (DT/AF) Active, not recruiting NCT03785964 Phase 3 Nirogacestat oral tablet;Placebo Oral Tablet
4 A Phase III, Double Blind, Randomized, Placebo-Controlled Trial of Sorafenib in Desmoid Tumors or Aggressive Fibromatosis (DT/DF) Active, not recruiting NCT02066181 Phase 3 Sorafenib Tosylate
5 A Multi-Center, Open-Label, Extension Study to Evaluate the Long-Term Safety, Efficacy, and Durability of EN3835 in the Treatment and Retreatment of Plantar Fibromatosis Enrolling by invitation NCT05254457 Phase 3
6 Open Label Phase II Clinical Trial of Myoma Immunotherapy Unknown status NCT03550703 Phase 2
7 Toremifene in Desmoid Tumor: Prospective Clinical Trial and Identification of Potential Molecular Targets Unknown status NCT02353429 Phase 2 Toremifene
8 A Phase II Trial of Imatinib for Patients With Aggressive Desmoid Tumor (Aggressive Fibromatosis) Completed NCT02495519 Phase 2 Imatinib
9 Phase II Pilot Study Of Moderate Dose Radiotherapy For Inoperable Aggressive Fibromatoses Completed NCT00030680 Phase 2
10 Phase II Study to Evaluate Glivec (Imatinib Mesylate) to Induce Progression Arrest in Aggressive Fibromatosis / Desmoid Tumors Not Amenable to Surgical Resection With R0 Intent or Accompanied by Unacceptable Function Loss Completed NCT01137916 Phase 2 Imatinib
11 Multicentric Phase I/II Study Evaluating the Efficacy and Toxicity of Imatinib in Adult Patients With Aggressive Fibromatosis That Cannot be Treated by Surgery or Curative Radiotherapy Completed NCT00287846 Phase 1, Phase 2 imatinib mesylate
12 Doxorubicin Eluting Intra-arterial Embolization for Aggressive Desmoid Fibromatosis Completed NCT03966742 Phase 2
13 A Pilot Study Evaluating the Use of mTor Inhibitor Sirolimus in Children and Young Adults With Desmoid-Type Fibromatosis Completed NCT01265030 Phase 1, Phase 2 Sirolimus
14 An Open-label, Multi-center, Phase 2 Study of Denosumab in Subjects With Giant Cell Rich Tumors of Bone Recruiting NCT03605199 Phase 2 Denosumab
15 A Safety, Pharmacokinetic and Efficacy Study of a y-Secretase Inhibitor, Nirogacestat (PF-03084014) in Children and Adolescents With Progressive, Surgically Unresectable Desmoid Tumors Recruiting NCT04195399 Phase 2 Nirogacestat
16 Phase 2, Double-blind, Randomized, Placebo-Controlled Study to Assess the Efficacy, Safety, and Tolerability of EN3835 vs Placebo in the Treatment of Plantar Fibromatosis Recruiting NCT05152173 Phase 2
17 A Phase 1/2 Study of Tegavivint (NSC#826393) in Children, Adolescents, and Young Adults With Recurrent or Refractory Solid Tumors, Including Lymphomas and Desmoid Tumors Recruiting NCT04851119 Phase 1, Phase 2 Tegavivint
18 DART: Dual Anti-CTLA-4 and Anti-PD-1 Blockade in Rare Tumors Recruiting NCT02834013 Phase 2
19 Phase II Trial of the Gamma-Secretase Inhibitor PF-03084014 in Adults With Desmoid Tumors/Aggressive Fibromatosis Active, not recruiting NCT01981551 Phase 2 PF-03084014
20 Randomized Phase II Trial Evaluating Compliance With Monitoring Conducted Either by a Hospital-based Physician in Person or by a Nurse in Remote Monitoring Not yet recruiting NCT05500391 Phase 2
21 Effect of Hydroxyurea as Treatment for Primary Desmoid Tumors in Adults and Children (CHP-914) Withdrawn NCT00978146 Phase 2 Hydroxyurea
22 A Pilot Study of Intralesional Injection of Triamcinolone Acetonide for Desmoid Tumors Completed NCT03627741 Phase 1 Triamcinolone Acetonide
23 Operative Hysteroscopy for Fibroma by Classic Resection Versus Morcellation: a Ramdomised Study Unknown status NCT02406898
24 3-dimensional Versus Conventional Laparoscopy in Patients Undergoing Total Hysterectomy for Benign Disease - A Randomised Clinical Trial Unknown status NCT02610985
25 Clinicopathological and Molecular Correlation of Acrochordon in Relation to Human Papillomavirus Infection Unknown status NCT00520078
26 Tailored Beta-catenin Mutational Approach in Extra-abdominal Sporadic Desmoids Tumor Patients Unknown status NCT02547831
27 A Comparison of Long Term Outcomes Following Total Laparoscopic Hysterectomy and Laparoscopic Supracervical Hysterectomy. Unknown status NCT01289314
28 Peripheral Primitive Fibromatosis. Study Evaluating a Simple Initial Monitoring With Search of Scalability Predictive Factors and Registration of Treatments in Case of Progression Unknown status NCT01801176
29 A Prospective Analysis of Active Observation in Patients With Desmoid-Type Fibromatosis Recruiting NCT04281381
30 The Project: EveryChild Protocol: A Registry, Eligibility Screening, Biology and Outcome Study Recruiting NCT02402244
31 Biomarkers for Tuberous Sclerosis Complex: An International Multicenter Observational Longitudinal Protocol Active, not recruiting NCT02654340
32 A COG Soft Tissue Sarcoma Diagnosis, Biology and Banking Protocol Active, not recruiting NCT00919269
33 Biomarker for Hyaline Fibromatosis Syndrome - An International, Multicenter, Epidemiological Protocol Active, not recruiting NCT03196115
34 National Clinical-biological Prospective Cohort of Incident Cases of Aggressive Fibromatosis Active, not recruiting NCT02867033
35 The Evaluation of Health-related Quality of Life Issues Experienced by Patients With Desmoid-type Fibromatosis Enrolling by invitation NCT04289077
36 Observational Prospective Study on Patients With Symptomatic Uterine Fibroids Treated With VizAblate® Intrauterine-ultrasound Guided RF Ablation Terminated NCT01998854
37 Pilot Investigation of 18F-FES PET/CT Imaging of Desmoid Tumors Terminated NCT02374931 Early Phase 1 F-18 16 Alpha-Fluoroestradiol
38 South Miami Hospital Fibroid Registry Terminated NCT02362009

Search NIH Clinical Center for Fibroma

Cochrane evidence based reviews: fibroma

Genetic Tests for Fibroma

Genetic tests related to Fibroma:

# Genetic test Affiliating Genes
1 Fibroma 28

Anatomical Context for Fibroma

Organs/tissues related to Fibroma:

MalaCards : Bone, Ovary, Small Intestine, Uterus, Heart, Skin, Breast

Publications for Fibroma

Articles related to Fibroma:

(show top 50) (show all 7510)
# Title Authors PMID Year
1
Identification of the most sensitive and robust immunohistochemical markers in different categories of ovarian sex cord-stromal tumors. 53 62
19033865 2009
2
Loss of the PTCH1 gene locus in cardiac fibroma. 53 62
18329553 2008
3
Mesenchymal-epithelial interactions involving epiregulin in tuberous sclerosis complex hamartomas. 53 62
18292222 2008
4
Is loss of heterozygosity at 9q22.3 (PTCH gene) and 19p13.3 (STK11 gene) involved in the pathogenesis of ovarian stromal tumors? 53 62
16084949 2005
5
Role of the hedgehog/patched signaling pathway in oncogenesis: a new polymorphism in the PTCH gene in ovarian fibroma. 53 62
15659790 2004
6
Origin of stellate giant cells in oral fibrous lesions determined by immunohistochemical expression of vimentin, HHF-35, CD68 and factor XIIIa. 53 62
15370129 2004
7
Solitary sclerotic fibroma of skin: a possible link with pleomorphic fibroma with immunophenotypic expression for O13 (CD99) and CD34. 53 62
14744088 2003
8
Ultrastructural and immunohistochemical characterization of the so-called giant multinucleate cells in cutaneous collagenomas. 53 62
12147091 2002
9
Fibroma and inflammatory myofibroblastic tumor of the heart. 53 62
11745071 2001
10
S100A6 expression in fibrohistiocytic lesions. 53 62
11401666 2001
11
Two cases of supernumerary ovary: one with large fibroma with Meig's syndrome and the other with endometriosis and cystic change. 53 62
11795834 2001
12
Cytokeratin expression in trichoblastic fibroma (small nodular type trichoblastoma), trichoepithelioma and basal cell carcinoma. 53 62
10215762 1999
13
Benign fibromatous tumors of the testis and paratesticular region: a report of 9 cases with a proposed classification of fibromatous tumors and tumor-like lesions. 53 62
9060599 1997
14
Pleomorphic hamartoma of the subcutis: a lesion with possible myogenous and neural lineages. 53 62
7593822 1995
15
An immunohistochemical study of odontogenic mixed tumours. 53 62
7543314 1995
16
Phenotypic characterisation of stellate and giant cells in giant cell fibroma by immunocytochemistry. 53 62
7523665 1994
17
So-called "immature dentinoma": a case presentation and histological comparison with ameloblastic fibrodentinoma. 53 62
8164161 1994
18
Histologic and immunohistochemical evidence for considering ovarian myxoma as a variant of the thecoma-fibroma group of ovarian stromal tumors. 53 62
7688213 1993
19
Mesothelial and related neoplasms in children and adolescents: a clinicopathologic and immunohistochemical analysis of eight cases. 53 62
1384016 1992
20
Cytoskeletal gene expression in normal and neoplastic human odontogenic epithelia. 53 62
1721670 1991
21
Immunohistochemical analysis for desmin in normal and neoplastic ovarian stromal tissue. 53 62
2159271 1990
22
Transformation of Cemento-Ossifying Fibroma into Osteosarcoma after Radiotherapy and Nine Endoscopic Surgeries. 62
35575211 2023
23
Juvenile psammomatoid ossifying fibroma in paranasal sinuses: A case report and literature review. 62
36324855 2023
24
Peripheral Ossifying Fibroma and Peripheral Odontogenic Fibroma: Close Relatives or Family? 62
35524033 2022
25
MDM2 Gene Amplification and Expression of MDM2 and CDK4 are Rare in Ossifying Fibroma of Craniofacial Bones. 62
35546651 2022
26
Ovarian Signet-ring Stromal Tumor: A Morphologic, Immunohistochemical, and Molecular Study of 7 Cases With Discussion of the Differential Diagnosis. 62
36040033 2022
27
Calcifying aponeurotic fibroma: Radiologic-pathologic analysis of ten cases and review of the literature. 62
36371890 2022
28
Unusual Findings in a Patient With Carney Complex due to a Novel PRKAR1A Mutation. 62
36456122 2022
29
The rare ventricular arrhythmia recurrence following fibroma resection: Can we predict who is at risk? 62
36336301 2022
30
Surgical Management of a Giant Left Ventricular Fibroma in a Newborn. 62
35502859 2022
31
Desmoplastic fibroma of the left 6th rib in a 35-year-old man: A case report. 62
35691815 2022
32
Chondromyxoid fibroma of the iliac bone: a brief radiological review. 62
36446478 2022
33
Skull base pathology - a diagnostic conundrum. 62
34924063 2022
34
Malignant fibroma presenting as a hypoglycemia and coma in a 45-year-old male patient: A case report. 62
36419579 2022
35
Clinical Impact of Cardiac Fibromas. 62
36055811 2022
36
Complex trigger wrist associated with carpal tunnel syndrome: a case report. 62
36371272 2022
37
Management of juvenile trabecular ossifying fibroma of bone of the maxilla in a child: A case report at a tertiary hospital in Northern Tanzania. 62
36257140 2022
38
A novel technique to repair orbital roof defects: irradiated homologous cadaveric rib (Tutoplast ®) graft in a recurrent frontal sinus ossifying fibroma. 62
36425586 2022
39
Juvenile psammomatoid ossifying fibroma of the maxilla and mandible: A systematic review of published case reports. 62
36325758 2022
40
Allogeneic Tendon Transplantation for the Treatment of Pathological Patellar Ligament Defect in Children: Technical Note and 4-Year Follow-Up. 62
36321600 2022
41
Recurrent FOSL1 rearrangements in desmoplastic fibroblastoma. 62
36426824 2022
42
Brown Tumors Belong to the Spectrum of KRAS -driven Neoplasms. 62
36040039 2022
43
Prevalence of benign bone lesions of the lower extremity in the pediatric spinal disorders: a whole-body imaging study. 62
35102057 2022
44
Three Cases of Mandibular Ossifying Fibroma in Cattle. 62
36116887 2022
45
Peripheral Ossifying Fibroma Veiling a Nasopalatine Duct Cyst: An Unusual Concurrence. 62
36452642 2022
46
Endoscopic Transnasal Management of Giant Paediatric Sinonasal Ossifying Fibroma. 62
36452801 2022
47
Oestrogen receptor expression distinguishes non-ossifying fibroma from other giant cell containing bone tumours. 62
35612673 2022
48
Ventricular arrhythmias after fibroma resection: Are patients still at risk? 62
36228870 2022
49
Histopathogenesis of bone- and soft-tissue tumor spectrum with USP6 gene rearrangement: multiple partners involved in the tissue repair process. 62
36205240 2022
50
A case of death of patient with ovarian fibroma combined with Meigs Syndrome and literature review. 62
36253781 2022

Variations for Fibroma

Expression for Fibroma

Search GEO for disease gene expression data for Fibroma.

Pathways for Fibroma

Pathways related to Fibroma according to GeneCards Suite gene sharing:

# Super pathways Score Top Affiliating Genes
1 11.95 VIM KRT7 DES ACTC1
2
Show member pathways
10.67 VIM DES ACTC1
3 10.1 SATB2 NF1

GO Terms for Fibroma

Cellular components related to Fibroma according to GeneCards Suite gene sharing:

# Name GO ID Score Top Affiliating Genes
1 intermediate filament cytoskeleton GO:0045111 9.1 VIM KRT7 DES

Biological processes related to Fibroma according to GeneCards Suite gene sharing:

# Name GO ID Score Top Affiliating Genes
1 endodermal cell fate commitment GO:0001711 9.26 CTNNB1 CDC73
2 stem cell proliferation GO:0072089 9.23 PTCH1 NF1 CTNNB1 CD34

Sources for Fibroma

2 CDC
6 CNVD
8 Cosmic
9 dbSNP
10 DGIdb
16 EFO
17 ExPASy
18 FMA
19 GARD
27 GO
28 GTR
29 HMDB
30 HPO
31 ICD10
32 ICD10 via Orphanet
33 ICD11
34 ICD9CM
35 IUPHAR
36 LifeMap
38 LOVD
40 MedGen
43 MeSH
44 MESH via Orphanet
45 MGI
48 NCI
49 NCIt
50 NDF-RT
52 NINDS
53 Novoseek
55 ODiseA
56 OMIM via Orphanet
57 OMIM® (Updated 08-Dec-2022)
61 PubChem
62 PubMed
64 QIAGEN
69 SNOMED-CT via HPO
70 Tocris
71 UMLS
72 UMLS via Orphanet
Content
Loading form....